Innoviva, Inc. SEC filings INVA
Innoviva, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 27, 2012. Its latest annual report, Form 10-K, was filed on Feb 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 4, 2026 | — |
| S-8 | Employee stock plan registration | Nov 13, 2023 | — |
| S-8 | Employee stock plan registration | Aug 7, 2014 | — |
| 424B5 | Prospectus supplement | Jan 18, 2013 | — |
| FWP | Free writing prospectus | Jan 18, 2013 | — |
| FWP | Free writing prospectus | Jan 18, 2013 | — |
| FWP | Free writing prospectus | Jan 16, 2013 | — |
| FWP | Free writing prospectus | Jan 16, 2013 | — |
| S-3ASR | Automatic shelf registration | Jan 16, 2013 | — |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlingame, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1080014
- Former names
- THERAVANCE INC (until Dec 7, 2015); ADVANCED MEDICINE INC (until Aug 2, 2000)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.